These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9552342)

  • 1. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design.
    Ferrari F; Bertoni M; Bonferoni CM; Rossi S; Caramella C; Bolhuis GK
    Pharm Dev Technol; 1996 Jul; 1(2):159-64. PubMed ID: 9552342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing for water: A new approach to understand disintegrant performance.
    Ekmekciyan N; Tuglu T; El-Saleh F; Muehlenfeld C; Stoyanov E; Quodbach J
    Int J Pharm; 2018 Sep; 548(1):491-499. PubMed ID: 30018010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
    Late SG; Banga AK
    AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of product brand-to-brand variability on superdisintegrant Performance. A case study with croscarmellose sodium.
    Zhao N; Augsburger LL
    Pharm Dev Technol; 2006; 11(2):179-85. PubMed ID: 16749528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a formulation for direct compression using a simplex lattice design.
    Van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1987 Oct; 9(5):265-73. PubMed ID: 3432036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1983 Aug; 5(4):165-71. PubMed ID: 6622211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
    Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
    Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of agglomerated directly compressible diluent consisting of brittle and ductile materials.
    Gohel MC; Jogani PD; Bariya SE
    Pharm Dev Technol; 2003; 8(2):143-51. PubMed ID: 12760565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calorimetric investigation on heat release during the disintegration process of pharmaceutical tablets.
    Lee J; Goodwin DJ; Dhenge RM; Nassar J; Zeitler JA
    Int J Pharm; 2024 Jul; 660():124315. PubMed ID: 38852747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a metformin effervescent floating tablet containing hydroxypropylmethylcellulose and stearic acid.
    Rajab M; Jouma M; Neubert RH; Dittgen M
    Pharmazie; 2010 Feb; 65(2):97-101. PubMed ID: 20225651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of lactose type on disintegration: An integral study on porosity and polymorphism.
    Janssen PHM; Berardi A; Kok JH; Thornton AW; Dickhoff BHJ
    Eur J Pharm Biopharm; 2022 Nov; 180():251-259. PubMed ID: 36270465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
    Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
    Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of ethanol on superdisintegrants and on tablets disintegration.
    Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
    Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.